N, N-Dimethylcarbamoylmethyl α, 2-Dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetateと各種添加剤との混合粉砕物の溶出特性とバイオアベイラビリティー
スポンサーリンク
概要
- 論文の詳細を見る
Ground mixture of N, N-dimethylcarbamoylmethyl α, 2-dimethyl-5H-[1] benzopyrano-[2,3-b] pyridine-7-acetate (1) with various pharmaceutical ingredients were prepared in order to investigate their dissolution behaviors and bioavailability. Taking into account the weakly basic property of 1,the dissolution rate was determined in the 2nd fluid (pH 6.8) of disintegration test, JP XI. Dissolution rates of the ground mixtures (1 : 1,w/w) of 1 with hydroxypropylcellulose-L (HPC-L), low substituted hydroxypropylcellulose (L-HPC) or lactose respectively, showed a significant increase compared with compound 1 alone. Three kinds of experimental fine granules were prepared ; type A : produced from ground mixture of 1,HPC-L, L-HPC and lactose ; type B : produced from physical mixture having the same composition as type A ; type C : produced 1,L-HPC and lactose. In these fine granules, only type A exhibited pH-independent dissolution profiles. Bioavailability study was carried out in beagle dogs whose gastric acidity was controlled in advance to low levels by administration of omeprazole. The test was conducted in a cross over design. Reflecting their dissolution characteristics, type A granules showed better bioavailability than the others. These results suggest that grinding is useful for the improvement of the dissolution property and bioavailability of 1,a weakly basic compound.
- 公益社団法人日本薬学会の論文
- 1989-12-25
著者
-
小川 建志
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
山田 一磨呂
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
小川 建志
吉富製薬株式会社中央研究所
-
横部 哲朗
吉富製薬株式会社中央研究所
-
山田 一磨呂
吉富製薬株式会社 中央研究所
-
川田 美和子
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.
-
柴田 祀行
吉富製薬株式会社中央研究所
-
川田 美和子
吉富製薬株式会社中央研究所
-
横部 哲朗
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
川田 美和子
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
関連論文
- Nitrofurantionの消化管吸収 : イヌにおける消化管通過時間の新規な測定法の有用性評価
- Effect of Small Intestinal Transit Time on Gastrointestinal Absorption of 2-[3-(3,5-Di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethyl Acetate, a New Non-steroidal Anti-inflammatory Agent
- Gastrointestinal Absorption of Chlorothiazide : Evaluation of a Method Using Salicylazosulfapyridine and Acetaminophen as the Marker Compounds for Determination of the Gastrointestinal Transit Time in the Dog
- 新規非ステロイド性抗炎症剤2-[3-(3,5-Di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethyl Acetateの消化管吸収における胆汁の寄与及び食餌の影響
- Effects of Meals on Gastric Emptying and Small Intestinal Transit Times of a Suspension in the Beagle Dog Assessed Using Acetaminophen and Salicylazosulfapyridine as Markers
- Salicylazosulfapyridine法によるビーグル犬の小腸通過時間の測定
- Utility of Gastrointestinal Physiology Regulated-Dogs : Bioavailability Study of a Commercial sustained-Release Dosage Form of Theophylline
- Gastrointestinal Physiology-Regulated Dogs : Utilization of a Bioavailability Study of a New Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]-diazepine, an Antagonist of Platelet-Activating Factor, and Its Preparations
- Biovavailability Study of Commercial Sustained-Release Preparations of Diclofenac Sodium in Gastrointestinal Physiology Regulated-Dogs
- 新規非ステロイド性抗炎症剤2-[3-(3,5-Di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethyl Acetateの消化管吸収の改善
- Comparative Pharmacokinetics of Sulpiride and N-[(1-Butyl-2-pyrrolidinyl)methyl]-2-methyl-5-sulfamoyl-2,3-dihydrobenzofuran-7-carboxamide Hydrochloride, a New Lipophilic Substituted Benzamide in Rats
- Effect of Gastric Acidity on Bioavailability of N, N-Dimethylcarbamoylmethyl α, 2-Dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate, a New Prodrug-Type Anti-inflammatory Agent
- Gastric pH Profile and Its Control in Fasting Beagle Dogs
- α, 2-Dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate類の合成と薬理活性及び生物薬剤学的特性
- (RS)-7-(2-Aminomethylmorpholino)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acidの結晶水の挙動
- N, N-Dimethylcarbamoylmethyl α, 2-Dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetateと各種添加剤との混合粉砕物の溶出特性とバイオアベイラビリティー
- Measurement of Gastric pH during Digestion of a Solid Meal in Dogs
- 新規Thromboxane合成酵素阻害剤Sodium 4-[α-Hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoate(Y-20811)の体内動態(第2報)イヌにおける未変化体及び主代謝物のPharmacokinetics
- 新規Thromboxane合成酵素阻害剤Sodium 4-[α-Hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoate(Y-20811)の体内動態(第1報)イヌにおける尿中代謝物の単離と構造決定
- Powder Coating Mixture of a Novel Anxiolytic, Y-23684 : Dissolution Characteristics and Bioavailability
- Gastric Acidity-Dependent Bioavailability of Commercial Sustained Release Preparations of Indomethacin, Evaluated by Gastric Acidity-Controlled Beagle Dogs
- 胃酸度調整ビーグル犬を用いたシンナリジンのバイオアベイラビリティーの評価
- 邦産キノコの成分研究(第8報) : イボテン酸関連化合物のマススペクトル その3 3-Alkoxyisoxazole類のフラグメンテーション
- 邦産キノコの成分研究(第7報) : イボテン酸関連化合物のスママペクトル その2 4-Isoxazolin-3-one類のフラグメンテーション